Pharmaceutical The £50 billion ($68.4 billion) bid for GlaxoSmithKline’s Consumer Healthcare business by Unilever was not only rejected by GSK, which is said to be looking for more than £60 billion, but was also strongly criticized by Unilever investors, prompting the British consumer conglomerate to issue a brief statement after London markets closed yesterday. 20 January 2022